Comparing Sacubitril/Valsartan Against Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure: A Systematic Review and Network Meta-analysis.

Yao Neng TeoYao Hao TeoNicholas L SynCeline Shuen Yin YoongAlex Jia Yang CheongCaitlin Fern WeeYoke-Ching LimChi-Hang LeeTiong-Cheng YeoPing ChaiRaymond C C WongWeiqin LinChing-Hui Sia

Published in: Clinical drug investigation (2021)

In patients with heart failure, sacubitril/valsartan was demonstrated to be superior to SGLT2 inhibitors in the treatment effect for the composite of heart failure hospitalisation and cardiovascular death, cardiovascular death, and long-term blood pressure.

Keyphrases

heart failure
blood pressure
ejection fraction
left ventricular
acute heart failure
cardiac resynchronization therapy
atrial fibrillation
hypertensive patients
replacement therapy